Tesi co-leads €5m funding round for Oura
Finnish VC firm Tesi has co-led a тЌ5m funding round for healthcare technology company Oura Health.
US-based Bold Capital Partners co-led the deal and introduced US industry specialists Stephen Friend and Kevin Lin to Oura's board.
The fresh capital will be used for the development of new products and to drive expansion in the US, where 60% of Oura's active users are based.
Previous funding
Lifeline Ventures led a $2.8m funding round for Oura (then Ouraring) in 2015, which included a $500,000 R&D loan from Tekes, the Finnish funding agency for innovation.
MIT Labs led a €5m series-A for the business in November 2016.
Company
Oura is a manufacturer of a healthcare device, the Oura Ring, that measures sleep activity and the body's physiological responses to everyday life. The company is headquartered in Oulu, Finland.
People
Tesi – Jussi Sainiemi (investment director).
Oura Health – Harpreet Rai (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









